Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study

INTRODUCTION: Olanzapine (OLA) is a common first-prescribed antipsychotic and has shown favorable efficacy in acutely exacerbated patients with schizophrenia. The mixed receptor activity of OLA and its greater affinity for serotonin 5-HT2A rather than dopamine D2 receptors are similar to those of cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahk, W.-M., Woo, Y. S., Park, S.-Y., Yoon, B.-H., Wang, S.-M., Kim, M.-D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479813/
http://dx.doi.org/10.1192/j.eurpsy.2023.2322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479813/
http://dx.doi.org/10.1192/j.eurpsy.2023.2322

Ejemplares similares